Sharon, MA, United States of America

Phyllis Losikoff

This inventor holds 1 USPTO granted patent. Top assignee: Rhode Island Council on Postsecondary Education. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phyllis Losikoff. Retrieved from https://idiyas.com/inventor/phyllis-losikoff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Phyllis Losikoff: Innovator in Immunology

Introduction

Phyllis Losikoff is a notable inventor based in Sharon, MA (US). She has made significant contributions to the field of immunology, particularly in the development of pharmaceutical compositions aimed at suppressing immunity in animals.

Latest Patents

Phyllis Losikoff holds a patent for a regulatory T cell epitope and hepatitis C virus homolog. This innovative pharmaceutical composition comprises an isolated T-cell epitope peptide containing the amino acid sequence of PLLLLLXLPXRA (SEQ ID NO: 5), where X represents an amino acid. This invention is crucial for advancing treatments related to immune suppression.

Career Highlights

Losikoff is affiliated with the Rhode Island Council on Postsecondary Education, where she continues to contribute her expertise in immunology and pharmaceutical development. Her work has been instrumental in enhancing our understanding of immune responses and potential therapeutic interventions.

Collaborations

Throughout her career, Phyllis has collaborated with esteemed colleagues such as Stephen Owen Gregory and Anne DeGroot. These partnerships have fostered a collaborative environment that promotes innovation and research in the field.

Conclusion

Phyllis Losikoff's contributions to immunology through her patent and collaborative efforts highlight her role as a significant innovator in the field. Her work continues to influence advancements in pharmaceutical compositions aimed at immune suppression.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…